Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer
Glossary on
off
Printer Friendly Page INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer

INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer

Clinicaltrials.gov identifier:
NCT02730338


Study Contact Information:

For additional information, please contact :

Anthony Treacy by email or

Jennette Sison by phone at: (415)885-3692 or by email

 

INTense Exercise foR surVivAL Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL)

About the Study

This study will determine if high intensity aerobic and resistance training (with supervised exercise) plus psychosocial support increases overall survival compared to psychosocial support alone (with self-directed exercise) in patients with castrate-resistant cancer. NOTE: This study is no longer enrolling people. 

Type of Study

This is a parallel assignment study with two arms. 

  • This is a  study, which means that participants will be placed into one of the two study arms by chance. Neither patients nor the research doctor will choose the group participants are placed in.
  • One arm is the supervised exercise group, where supervised high intensity aerobic and resistance exercise will taper to self-management with psychosocial support. 
  • The second arm will be a self-directed exercise group with psychosocial support. 

What the Study Entails

  • Study participants must be able to travel to one of the study-designated exercise facilities
    • up to three days per week during cycle 0 (4 weeks)
    • two days per week for cycles 1-8 (32 weeks), and
    • once per week for cycles 9-11 (12 weeks).
  • Participants will be asked to complete questionnaires and undergo physical assessments every three cycles.
  • Participants must be able to attend exercise testing visits as required by the study.
  • Participants will be studied for up to five years.

Study Locations

United States

  • Colorado
    • Denver, CO: UC Denver
    • Contact: Elizabeth Kessler by email
  • Oregon
    • Portland, OR: Oregon Health & Science University 
    • Contact: Kerri Winters-Stone by email
  • Washington
    • Seattle, WA Fred Hutchinson Cancer Centre
    • Contact: Stephen Plymate by email     
  • Canada, Alberta

Canada

  • Alberta
    • Edmonton, Alberta: University of Alberta 
    • Contact: Kerry Courneya by email        

Other international sites are open in the following countries:

  • Australia
  • China
  • Germany
  • Netherlands
  • United Kingdom

 

 

This Study is Open To:

NOTE: This study is closed.

This Study is Not Open To:

NOTE: This study is closed.